These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2843787)

  • 21. N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis.
    Koek W; Woods JH; Colpaert FC
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1017-25. PubMed ID: 2193142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioural and electoencephalographic interactions between haloperidol and PCP/sigma ligands in the rat.
    Sagratella S; Scotti de Carolis A; Pèzzola A; Popoli P
    Psychopharmacology (Berl); 1991; 105(4):485-91. PubMed ID: 1685250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.
    Mizoule J; Meldrum B; Mazadier M; Croucher M; Ollat C; Uzan A; Legrand JJ; Gueremy C; Le Fur G
    Neuropharmacology; 1985 Aug; 24(8):767-73. PubMed ID: 3018617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties.
    Swedberg MD; Ellgren M; Raboisson P
    J Pharmacol Exp Ther; 2014 Apr; 349(1):155-64. PubMed ID: 24472725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine.
    Nicholson KL; Jones HE; Balster RL
    Behav Pharmacol; 1998 May; 9(3):231-43. PubMed ID: 9832937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the discriminative stimulus and reinforcing effects of gammahydroxybutyrate (GHB).
    Beardsley PM; Balster RL; Harris LS
    Psychopharmacology (Berl); 1996 Oct; 127(4):315-22. PubMed ID: 8923566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists.
    Lu Y; France CP; Woods JH
    J Pharmacol Exp Ther; 1992 Nov; 263(2):499-504. PubMed ID: 1432686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phencyclidine-like catalepsy induced by the excitatory amino acid antagonist DL-2-amino-5-phosphonovalerate.
    Koek W; Kleer E; Mudar PJ; Woods JH
    Behav Brain Res; 1986 Mar; 19(3):257-9. PubMed ID: 2870725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analgesic effects of phencyclidine-like drugs in rhesus monkeys.
    France CP; Snyder AM; Woods JH
    J Pharmacol Exp Ther; 1989 Jul; 250(1):197-201. PubMed ID: 2501476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the reinforcing and discriminative stimulus effects of the N-methyl-D-aspartate competitive antagonist NPC 17742 in rhesus monkeys.
    Nicholson KL; Jones HE; Balster RL
    Behav Pharmacol; 1997 Oct; 8(5):396-407. PubMed ID: 9832979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discriminative stimulus properties of ketamine stereoisomers in phencyclidine-trained rats.
    Brady KT; Balster RL
    Pharmacol Biochem Behav; 1982 Aug; 17(2):291-5. PubMed ID: 7134239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MK-801 and related compounds in monkeys: discriminative stimulus effects and effects on a conditional discrimination.
    France CP; Moerschbaecher JM; Woods JH
    J Pharmacol Exp Ther; 1991 May; 257(2):727-34. PubMed ID: 2033515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationships of arylcyclohexylamines as discriminative stimuli in pigeons.
    McMillan DE; Evans EB; Wessinger WD; Owens SM
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1086-92. PubMed ID: 2849658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the pharmacologic effects of N-allylnormetazocine and phencyclidine: sensitization, cross-sensitization, and opioid antagonist activity.
    Iwamoto ET
    Psychopharmacology (Berl); 1986; 89(2):221-9. PubMed ID: 3088640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of dopaminergic system in the nucleus accumbens in the discriminative stimulus effects of phencyclidine.
    Mori A; Noda Y; Nagai T; Mamiya T; Furukawa H; Nabeshima T
    Neuropharmacology; 2002 May; 42(6):764-71. PubMed ID: 12015202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: pharmacological and behavioral characterization of intermediate levels of drug lever selection.
    Koek W; Colpaert FC; Vignon J
    J Pharmacol Exp Ther; 1993 Feb; 264(2):746-56. PubMed ID: 8437123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discriminative properties of phencyclidine in mice: generalization to ketamine and monohydroxy metabolites.
    Middaugh LD; Favara JP; Boggan WO; Stringer AJ
    Psychopharmacology (Berl); 1988; 96(3):381-4. PubMed ID: 3146772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of phencyclidine-like drugs on punished behavior in rats.
    Porter JH; Wiley JL; Balster RL
    J Pharmacol Exp Ther; 1989 Mar; 248(3):997-1002. PubMed ID: 2539469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discriminative stimulus effects of N-substituted analogs of phencyclidine in rhesus monkeys.
    Solomon RE; Herling S; Domino EF; Woods JH
    Neuropharmacology; 1982 Dec; 21(12):1329-36. PubMed ID: 7155312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.